Madison WI 黑色素瘤临床试验
15项针对 黑色素瘤的研究正在 Madison及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
招募中1/2 期
- UW Hospital and Clinics, Madison
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
招募中3 期
- University of Wisconsin Carbone Cancer Center, Madison
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
招募中2 期
- Local Institution - 0134, Madison
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
招募中2 期
- University of Wisconsin Carbone Cancer Center, Madison
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
招募中1/2 期
- University of Wisconsin-Madison Carbone Cancer Center, Madison
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
招募中1/2 期
- The Board of Regents of the University of Wisconsin, Madison
Project: Every Child for Younger Patients With Cancer
招募中观察性研究
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
招募中1/2 期
- University of Wisconsin- Madison, Madison
Neoadjuvant Darovasertib in Primary Uveal Melanoma
招募中3 期
- University of Wisconsin Health, Madison
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
招募中2/3 期
- University Of Wisconsin Carbone Cancer Center - University Hospital, Madison
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中观察性研究
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
招募中观察性研究
- University of Wisconsin Hospitals and Clinics (UWHC), Madison
In Vivo Liquid Biopsy of Melanoma (Cytophone)
招募中欢迎健康志愿者
- SSM Health Dean Medical Group Specialty Services, Madison
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
招募中
- University of Winsconsin Carbone Cancer Center-Eastpark medical Center, Madison
- University of Wisconsin Carbone Cancer Center, Madison
其他城市的 黑色素瘤试验
- Houston, TX59 项研究
- New York City, NY38 项研究
- Los Angeles, CA34 项研究
- Nashville, TN33 项研究
- Pittsburgh, PA31 项研究
- Boston, MA26 项研究
- Philadelphia, PA23 项研究
- San Francisco, CA22 项研究
- Atlanta, GA21 项研究
- Durham, NC21 项研究
- St. Louis, MO21 项研究
- Columbus, OH21 项研究
Madison的其他研究
- 前列腺癌29 项研究
- 结直肠癌22 项研究
- 乳腺癌22 项研究
- 转移性癌症21 项研究
- 非小细胞肺癌16 项研究
- 急性髓系白血病16 项研究
- 癌症（所有类型）14 项研究
- 卵巢癌13 项研究
- 胃癌11 项研究
- 肺癌10 项研究
- 胰腺癌10 项研究
- 多发性骨髓瘤9 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。